Stanford, California
Professor, Cardiothoracic Surgery
Stanford University School of Medicine
Medical Director, Catheterization and Angiography Laboratories
Stanford University Medical Center
SCHEDULE FOR VEITHsymposium™
Tuesday, November 14, 2017
Session Moderator
SESSION-3: TYPE B AORTIC DISSECTIONS (TBADS) AND THEIR TREATMENT: THORACIC AND THORACOABDOMINAL ANEURYSMS (TAAAS)
Presenter
SESSION 2: NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC ARCH LESIONS AND AORTIC DISSECTIONS
Key New Developments And Progress In The Treatment Of TBAD Patients
7:46 AM - 7:51 AM

View Slides in PDF
Wednesday, November 15, 2017
Session Moderator
SESSION-39: MORE TOPICS RELATED TO THE THORACIC AORTA, TEVAR, AORTIC DISSECTIONS, TAAAS AND THEIR TREATMENT
Presenter
SESSION 24: MORE ON LOWER EXTREMITY OCCLUSIVE DISEASE – NEW DEVELOPMENTS AND HOT TOPICS RELATING TO STENTS
Update On New Developments With The Zilver PTX DES (Cook) For SFA-Pop Lesions: Its Effectiveness Is Maintained In Longer Lesions; Patients With Poor Run-Off, Diabetes And Chronic Renal Failure; And Asian Patient Groups
8:16 AM - 8:21 AM

View Slides in PDF
Thursday, November 16, 2017
Presenter
SESSION 60: NEW DEVELOPMENTS AND DEVICES FOR LOWER EXTREMITY STENTS, BALLOONS, ATHERECTOMY AND STENT-GRAFTS; TECHNICAL ADVANCES TO IMPROVE THEIR USE
Status Of Bioresorbable Stents To Treat Lower Extremity Lesions: 3-Year Results Of The ESPRIT Trial: Advantages, Limitations And Future Prospects
2:06 PM - 2:11 PM

View Slides in PDF
Friday, November 17, 2017
Presenter
SESSION 92: ENDOVASCULAR AND OPEN SOLUTIONS FOR INFERIOR VENA CAVA TUMORS AND OCCLUSIONS, VENA CAVA FILTRATION STRATEGIES, PITFALLS, AND COMPLICATIONS AND MORE ABOUT ILIAC VEIN STENTING
The NOVATE SENTRY Trial With A Novel Bio-Convertible IVC Filter: 130 Patients Enrolled With CTV Follow-Up At 1-Year
4:43 PM - 4:48 PM

View Slides in PDF
 
previous next